Clinical Trials Browser

Phase 2 × apixaban × Plasma cell × Clear all

NCT04106700 2021-02-15

Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs

Phase 2 Terminated

Classical hematologyPlasma cell

Multiple Myeloma, Venous Thromboembolism